reported that FBXO22 blocks tumour metastasis via modification of lysine demethylase 5A (KDM5A) ubiquitin and modulates H3K4me3 demethylation in triple‐negative breast cancer (TNBC).44 Here, KDM5A is linked to neoplasm.